Association of four polymorphisms in the death receptor 4 gene with cancer risk: an updated meta-analysis

Area of Science:

• Genetics
• Cancer Research
• Molecular Epidemiology

Background:

• The association between specific genetic polymorphisms and cancer risk remains an area of active investigation.
• Consensus on the role of DR4 C626G, A683C, A1322G, and G422A polymorphisms in cancer susceptibility is lacking.

Purpose of the Study:

• To conduct a comprehensive meta-analysis assessing the relationship between four DR4 polymorphisms (C626G, A683C, A1322G, G422A) and overall cancer risk.
• To clarify the inconsistent findings in previous studies regarding these genetic variations and cancer development.

Main Methods:

• A meta-analysis was performed, synthesizing data from 16 relevant studies.
• Included studies comprised a total of 4,261 cancer cases and 4,598 controls for the C626G polymorphism, with varying numbers for other polymorphisms.
• Statistical analyses were conducted using different genetic models to evaluate associations.

Main Results:

• The DR4 C626G polymorphism showed a slight increase in cancer risk (OR=1.12). A subgroup analysis revealed a significantly elevated risk for lung cancer in heterozygote comparisons (OR=1.76).
• The DR4 A1322G polymorphism was significantly associated with increased cancer risk across multiple genetic models (heterozygote OR=1.21, dominant OR=1.21, allele G vs. A OR=1.17).
• No significant association was found between the DR4 A683C and G422A polymorphisms and cancer risk in any genetic model.

Conclusions:

• The DR4 C626G and A1322G polymorphisms are associated with an elevated risk of developing cancer.
• The DR4 A683C polymorphism demonstrates a minimal association with cancer risk.
• Further research may be warranted to elucidate the precise mechanisms underlying these genetic associations with cancer.